Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

GSK abandons Parkinson’s drug

May 1, 2013 Research and Development, Sales and Marketing GSK, IPX066, Parkinson's

GlaxoSmithKline has terminated its three-year old agreement with Impax Pharmaceuticals to develop investigational Parkinson’s disease drug IPX066. “The decision has …
News

Pfizer and Merck create major diabetes alliance

April 30, 2013 Research and Development, Sales and Marketing Merck, Pfizer, diabetes

Pfizer and Merck have unveiled a major new alliance in diabetes which is likely to raise the stakes in the …
News
hooper

Evolution Marketing Research hires senior director

April 30, 2013 Medical Communications, Research and Development, Sales and Marketing Evolution marketing research, david hooper

Healthcare marketing agency Evolution Marketing Research has appointed David Hooper to the firm as senior director, Research. Hooper brings more …
Appointment
ctca_-gerard-van-grinsven-90-2-1367000496mr

CTCA changes leadership

April 29, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CTCA

The Cancer Treatment Centers of America (CTCA) network has made a change in its executive leadership with the appointment of  …
Appointment
Merck image

Melanoma breakthrough for Merck

April 26, 2013 Research and Development, Sales and Marketing FDA, Merck, lambrolizumab, melanoma

Merck’s pipeline has been given a boost by an FDA decision to designate early-stage investigational drug lambrolizumab as a breakthrough …
News

Pharma R&D ‘untenable’

April 25, 2013 Research and Development, Sales and Marketing GlobalData, R&D

The current model by which pharma carries out R&D is ‘untenable’, according to a new report. But the research, from …
News

Boehringer’s online PMCPA breach

April 25, 2013 Medical Communications, Research and Development, Sales and Marketing ABPI, AF, Boehringer, PMCPA

Boehringer Ingelheim has failed to uphold high standards, according to the PMCPA, which enforces the ABPI Code of Practice, over …
News

Navigating Cancer hires VP from InVentiv Health

April 25, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentic Health, navigating cancer

Cancer support service company Navigating Cancer has appointed Suzanne Greenwood to the firm as vice president, Bio-Pharmaceutical Services. Greenwood has …
Appointment

£50m oncology fund pays out

April 24, 2013 Research and Development, Sales and Marketing Cancer, ICR, MPS1

The Institute of Cancer Research (ICR) in London has become the first recipient of money from a £50 million fund …
News

Roche restructures life science business

April 24, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, Roche, US, cuts

Roche is to cut around 170 jobs in Europe and the US as part of a restructure of its life …
News
msi

The competitor room comes of age

April 24, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, competitor room

It was great to be back at SonoPharm, it was so still at this time of day and she went …
Feature

Specialist publisher acquires Pharmafile portfolio

April 24, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Samedan, Wiley, pharmafile

Samedan Ltd has extended its range of market-leading pharmaceutical magazines with the acquisition of the Pharmafile portfolio. The London-based firm …
News
Merck image

HCV agreement for Merck and BMS

April 23, 2013 Research and Development, Sales and Marketing BMS, HCV, Merck

Merck & Co and Bristol-Myers Squibb have signed a non-exclusive agreement to conduct a Phase II trial looking at a …
News
astrazeneca image

AstraZeneca signs $200m nanomedicine deal

April 23, 2013 Research and Development, Sales and Marketing AstraZeneca, bind therapeutics, nanomedicine

AstraZeneca has signed an agreement to develop and commercialise a cancer nanomedicine from US firm Bind Therapeutics’ stable of Accurins. …
News
mike_narachi_orexigen

Orexigen’s chief executive elected to PhRMA Board

April 23, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PhRMA, orexigen

Biopharma firm Orexigen has announced that its president and chief executive Michael Narachi has been elected to the Board of …
Appointment
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026